AlphaFold2 structures guide prospective ligand discovery
Source check: Needs source check. Not independent scientific confirmation.
Finding: AlphaFold2 structures guide prospective ligand discovery. AlphaFold2 predicted structures of the sigma-2 and 5-HT2A receptors were used as unrefined docking targets for large library screens. Hundreds of new molecules were tested; hit rates and affinities were similar to experimental-structure docking, and a cryo-EM structure of one 5-HT2A ligand was determined. Evidence limits: Full text not read; generality beyond two receptors is not established by the abstract. The AI model supplies the target structure, not the ligand ranking. Reviewed from Europe PMC abstract only.
Technology: AlphaFold2 models used for structure-based docking
Family AlphaFold: profile · models page
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- AlphaFold2 predicted structures of the sigma-2 and 5-HT2A receptors were used as unrefined docking targets for large library screens.
- Test and result
- Hundreds of new molecules were tested; hit rates and affinities were similar to experimental-structure docking, and a cryo-EM structure of one 5-HT2A ligand was determined.
- Limitation / still unknown
- Full text not read; generality beyond two receptors is not established by the abstract. The AI model supplies the target structure, not the ligand ranking.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://europepmc.org/article/MED/38753765
Needs source check · editorial details
The source has not been fully checked or contains conflicting information. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review scope and date are not recorded; source checked does not establish full-text review.
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 4/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.